老带新
BCMA/TNFRSF17 His Tag Protein, Human
1/4

BCMA/TNFRSF17 His Tag Protein, Human

分享
品牌: UA BIOSCIENCE
pdf 下载产品说明书
用小程序,查商品更便捷
收藏
对比对比
咨询咨询
分子量:

15-19kDa (Reducing)

纯度:

>95% by SDS-PAGE

产品介绍
产品介绍
产品信息
荧光素标记
氨基酸序列

Met1-Ala54, with C-terminal 8*His MLQMAGQCSQNEYFDSLLHACIPCQLRCSSNTPPLTCQRYCNASVTNSVKGTNAGGGSHHHHHHHH

分子量

15-19kDa (Reducing)

纯度

>95% by SDS-PAGE

内毒素水平
<0.1EU/μg
性状
Lyophilized powder
表达系统
HEK293
缓冲体系
PBS, pH7.4
标签
His Tag
种属
Human
电泳JSON
[{"imgUrl":"https://univ-njua.oss-cn-shanghai.aliyuncs.com/prod/202209/21fec9cd5fcd4d71bf19329528ba7e4a.png","description":"1μg(R: reducing conditions, N: non-reducing conditions)."}]
背景
背景

BCMA (The B-cell maturation antigen), also designated as TNFRSF17, belongs to the tumor necrosis factor receptor superfamily, which is a family of cytokine receptors. BCMA is encoded by a 2.92-kb TNFRSF17 gene located on the short arm of chromosome 16 (16p13.13) and composed of 3 exons separated by 2 introns. There are four natural splice variants of human BCMA that present with different receptor binding affinities, membrane-anchoring ability, and intracellular domain signaling. BCMA main ligands are the cytokines B-cell activating factor and a proliferation-inducing ligand. The interaction between BCMA and its ligands activates the NF-κB signaling pathway that plays an important role in B-cell proliferation and maturation and is essential for the survival of long-lived bone marrow plasma cells. BCMA is expressed preferentially on mature B cells and has minimal expression on hematopoietic stem cells or other cell types. The BCMA has emerged as a central target in multiple myeloma (MM). In preclinical studies, overexpression of BCMA and the interaction with is ligand, a proliferation-inducing ligand (APRIL), was found to promote MM progression in vivo and augment MM cell growth and survival through induction of multiple signaling cascades, including protein kinase B (AKT), MAPK, and nuclear factor (NF)-κB. Additionally, BCMA has been shown to be solubilized at high levels in serum of patients with MM (sBCMA). This form of sBCMA binds to B-cell activating factor (BAFF). The role of BAFF is to stimulate normal B-cell and plasma cell development; however, this functioning is prevented when it is bound by BCMA in the serum, thereby leading to decreased polyclonal immunoglobulin levels in patients with MM.

制备和贮存
溶解方法

Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.

保存方式

· 12 months from date of receipt, lyophilized powder stored at -20 to -80℃.

· 3 months, -20 to -80℃ under sterile conditions after reconstitution.

· 1 week, 2 to 8℃ under sterile conditions after reconstitution.

· Please avoid repeated freeze-thaw cycles.

数据库链接
Accession

参考图片

1μg(R: reducing conditions, N: non-reducing conditions).

Immobilized BCMA/TNFRSF17 His Tag Protein, Human (Cat. No. UA010083) at 2.0μg/mL (100μL/well) can bind Anti-Human BCMA (Belantamab) with EC50 of 0.68-0.88ng/mL.

The purity of BCMA/TNFRSF17 His Tag Protein, Human is greater than 95% as determined by SEC-HPLC.

Immobilized BCMA/TNFRSF17 His Tag Protein, Human (Cat. No. UA010083) at 2.0μg/mL (100μL/well) can bind Anti-Human BCMA (Belantamab), LotA with EC50 of 1.00-1.55ng/mL. LotB with EC50 of 1.15-1.66ng/mL.

声明 :本官网所有报价均为常温或者蓝冰运输价格,如有产品需要干冰运输,需另外加收干冰运输费。
货号:
UA010083-100μg
一键复制
询价
供应商现货
100μg
500μg
选择数量
当前规格1件起购 
配送至
预计3-5个工作日送达,快递: 免运费,若需干冰额外收费